中枢介导性腹痛综合征中西医治疗进展
Centrally Mediated Abdominal Pain Syndrome of Abdominal Pain Syndromes of Traditional Chinese and Clinical Medicine
DOI: 10.12677/TCM.2023.129375, PDF,   
作者: 田连华:三峡大学健康医学院,湖北 宜昌;三峡大学中医医院/宜昌市中医医院,脾胃病科,湖北 宜昌;张继红:三峡大学中医医院/宜昌市中医医院,脾胃病科,湖北 宜昌
关键词: 中枢介导性腹痛综合征功能性腹痛综合征中西医Centrally Mediated Abdominal Pain Syndrome Functional Abdominal Pain Syndrome Traditional Chinese and Clinical Medicine
摘要: 中枢介导性腹痛综合征(CAPS)是一种呈持续的或近乎持续性腹痛为主要表现综合征。其病因及发病机制尚不完全明确,目前多数学者认为其发病机制主要为内脏高敏感、脑–肠互动、社会心理因素等。该类病患的发病多与情绪相关,因反复多次住院,不仅增添患者焦虑情绪,且占用大量医疗资源。目前针对CAPS患者的治疗尚无统一的共识意见,西医治疗多以缓解症状为主,但病情易反复,且患者医从性较差。中医药通过辨证施治,治疗该病具有独特优势,需不断挖掘,寻找更加系统、规范的治疗共识;中医外治历史悠久,种类繁多,前景广阔;中西结合更具疗效,需不断探索,寻求更佳治疗方案。本文通过查阅相关文献,从现代医学、传统医学的内服与外治以及现代医学与传统医学相结合等方面进行概述,以期为临床治疗提供参考价值。
Abstract: Centrally mediated abdominal pain syndrome (CAPS) is a kind of continuous or nearly persistent abdominal pain as the main performance syndrome. Its etiology and pathogenesis is not fully clear, at present most of scholars believe that the main pathogenesis as visceral high sensitive, brain-im interaction and social psychological factors. The patient’s disease associated with mood, more because of repeated several times in the hospital, not only add patients’ anxiety, and take up a lot of medical resources. At present for the treatment of patients with CAPS, there is no uniform consensus opinion, clinical medicine more give priority to in order to alleviate the symptoms, but the illness easily repeatedly, and poor patients cure from sex. By evidence-based medicine of traditional Chinese medicine, treatment of the disease has a unique advantage, the need to develop, looking for a more systematic, standardized treatment; external treatment of traditional Chinese medicine has a long history and a wide range of prospect; traditional Chinese and clinical combined with more curative effect, need to continuously explore, to seek better treatments. In this paper, by consulting relevant literature, from the internal and external treatment of clinical medicine and traditional Chinese medicine and clinical medicine combined with traditional Chinese medicine and so on are summarized, so as to provide reference for clinical value.
文章引用:田连华, 张继红. 中枢介导性腹痛综合征中西医治疗进展[J]. 中医学, 2023, 12(9): 2505-2510. https://doi.org/10.12677/TCM.2023.129375

参考文献

[1] Schmulson, M.J. and Drossman, D.A. (2017) What Is New in Rome IV. Journal of Neurogastroenterology and Motility, 23, 151-163. [Google Scholar] [CrossRef] [PubMed]
[2] Suzuki, H. (2017) The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia. Journal of Neurogastroenterology and Motility, 23, 325-333. [Google Scholar] [CrossRef] [PubMed]
[3] Sperber, A.D. and Drossman, D.A. (2010) Functional Abdominal Pain Syndrome: Constant or Frequently recUrring Abdominal Pain. The American Journal of Gastroenterology, 105, 770-774. [Google Scholar] [CrossRef] [PubMed]
[4] 闫斌, 崔立红, 彭丽华, 等. 海军官兵功能性腹痛综合征的流行病学调查[J]. 解放军医学院学报, 2013(6): 547-549.
[5] 阮小东. 武汉市儿童功能性腹痛综合征患病率及其影响因素[J]. 职业与健康, 2016, 32(6): 774-776.
[6] 中华医学会, 中华医学会杂志社, 中华医学会消化病学分会, 等. 慢性腹痛基层诊疗指南(2019年) [J]. 中华全科医师杂志, 2019,18(7): 618-627.
[7] 张晖. 麻醉性镇痛药与胃肠动力关系研究进展[J]. 国外医学∙麻醉学与复苏分册, 2003, 24(2): 70-72.
[8] 张育珠, 徐梅玲. 慢性疼痛药物治疗的副作用及处理[J]. 青海医药杂志, 2008(3): 78-80.
[9] Xu, R., Wang, Y. and Han, W. (2023) Randomized Clinical Trial: The Effects of Pregabalin for Centrally Mediated Abdominal Pain Syndrome. Therapeutic Advances in Gastroenterology, 16. [Google Scholar] [CrossRef] [PubMed]
[10] Yang, H., Chen, H. and Hu, B. (2021) Evaluation of the Short-Term Efficacy of Local Analgesic (Lidocaine) and Opioid Analgesic (Sufentanil) on Patients with Centrally Mediated Abdominal Pain Syndrome: A Randomized Controlled Trial. Therapeutic Advances in Gastroenterology, 14. [Google Scholar] [CrossRef] [PubMed]
[11] 王玥, 许婷, 乔月芹, 等. 度洛西汀治疗中枢介导的腹痛综合征的疗效研究[J]. 胃肠病学, 2020, 25(11): 666-669.
[12] 杜晨辉, 刘露路, 王珏, 等. 文拉法辛治疗中枢介导性腹痛综合征的临床研究[J]. 现代医药卫生, 2020, 36(8): 1125-1127.
[13] 李康, 魏良洲, 林立波, 等. 联合帕罗西汀治疗功能性腹痛综合征的临床疗效[J]. 临床医学研究与实践, 2018, 3(26): 14-16.
[14] Fu, X.R., Liang, Q., Hu, J., et al. (2022) Systematic Evaluation and Meta-Analysis of Chinese Medicine in the Treatment of Centrally Mediated Abdominal Pain Syndrome. Medicine, 101, e30575. [Google Scholar] [CrossRef
[15] 张晓, 宋娜. 从中气论治功能性腹痛综合征[J]. 中国中医药现代远程教育, 2017, 15(3): 54-56.
[16] 钟华文, 罗立媛. 加味柴胡疏肝散治疗肝郁气滞型功能性腹痛综合征的疗效观察[J]. 中国医药科学, 2021, 11(21): 108-111.
[17] 景洁, 路晶, 苏娟萍. 苏娟萍辨治中枢介导的腹痛综合征临床经验分析[J]. 临床合理用药杂志, 2019, 12(10): 53-55.
[18] 张旭, 李梅芳, 胡思源, 等. 中医名方从脾论治儿童功能性腹痛的临床应用[J]. 中医儿科杂志, 2023, 19(2): 4-6.
[19] 王晓璇, 李新民, 陆丘, 等. 李新民教授从“脾胃枢机”论治小儿功能性腹痛临证经验[J]. 中国民族民间医药, 2022, 31(15): 73-76.
[20] 陈雨波, 朱莹. 穴位埋线联合黛力新治疗中枢介导腹痛综合征肝郁脾虚证临床观察[J]. 山西中医, 2019(9): 28-29, 32.
[21] 李所. 平衡拔罐疗法治疗功能性腹痛临床观察[J]. 中国中医药现代远程教育, 2021, 19(5): 113-115.
[22] 徐聪, 黄晨. 温针灸治疗功能性腹痛临床体会[J]. 实用中医药杂志, 2022, 38(11): 2013-2014.
[23] 林佛龙, 王旭波, 劳建昌. 小儿推拿联合中药热奄包在儿童功能性腹痛患者中的疗效观察及安全性研究[J]. 哈尔滨医药, 2022, 42(4): 128-130.
[24] 王云鹏, 曹志群. 中西医结合治疗功能性腹痛综合征40例临床观察[J]. 中国民族民间医药, 2019, 28(17): 79-82.
[25] 饶娟, 黄丽娟, 张娟, 等. 穴位埋线联合黛力新治疗功能性腹痛综合征临床观察[J]. 光明中医, 2022, 37(8): 1408-1411.
[26] 唐国柱. 半夏泻心汤加减联合洛芬待因治疗功能性腹痛综合征临床观察[J]. 中国处方药, 2019, 17(9): 136-137.
[27] 董璐璐, 张熠, 徐露佳, 等. 刺五加联合黛力新对功能性腹痛的治疗效果分析[J]. 世界最新医学信息文摘, 2019, 19(78): 121-122.